Home  |  News  | Member Log In    Twitter Facebook   

What Interests You?

You can contribute by participating in targeted topic discussions that help to inform our research. To participate or suggest an area for future NEHI discussion, contact us at membership@nehi.net.

Web Conferences

We’re investigating new ways to keep you informed on pressing health care issues. Contact us at membership@nehi.net with your topics of interest.

Health Reform’s New Frontier:
Balancing Cost, Value and Innovation: A Panel Discussion

Place: Genzyme Corporation - Cambridge, MA   |   Date: February 23, 2010


Photos from the Event

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

From left, panelists Dr. Joshua Boger, Vertex Pharmaceuticals; Dr. Richard Bohmer, Harvard Business School; Dr. Alice A. Tolbert Coombs, Massachusetts Medical Society; Dr. Jeffrey Flier, Harvard Medical School; Dr. Meredith B. Rosenthal, Harvard School of Public Health.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

From left, Dr. Jeffrey Flier, Harvard Medical School; Dr. Wendy Everett, NEHI; Michael Ferguson, Philips Healthcare; James Roosevelt, Jr., Tufts Health Plan.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Alison DeCourcey (left) and Carolyn Buck-Luce, Ernst & Young LLP.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Laurel Sweeney, Philips Healthcare (left), and Theresa Gorenc, Medical Imaging and Technology Alliance.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Panel members during the forum.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

From left, moderator Dr. Richard Bohmer, Harvard Business School; Dr. Joshua Boger, NEHI chair and Founder and former CEO of Vertex Pharmaceuticals; Dr. Alice A. Tolbert Coombs, Massachusetts Medical Society.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Donald Thieme, Massachusetts Council of Community Hospitals, during the audience question-and-answer session following the forum.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Moderator Dr. Richard Bohmer, Harvard Business School.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Dr. Wendy Everett, NEHI; Dr. John Fallon, Blue Cross Blue Shield Massachusetts; panelists Dr. Joshua Boger, Vertex Pharmaceuticals; Dr. Alice A. Tolbert Coombs, Massachusetts Medical Society; Dr. Jeffrey Flier, Harvard Medical School; and Dr. Meredith B. Rosenthal, Harvard School of Public Health.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Dr. Ken Kaitin, Tufts Center for the Study of Drug Development; Dr. Beverly Lorell, King & Spalding, LLP

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

From left, moderator Dr. Richard Bohmer, Harvard Business School; Dr. John Fallon, Blue Cross Blue Shield Massachusetts; Dr. Joshua Boger, Vertex Pharmaceuticals; Dr. Alice Coombs, Massachusetts Medical Society

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Marci Sindell, Atrius Health.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Jean Hetherington, GlaxoSmithKline, Inc.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

James Roosevelt, Jr., Tufts Health Plan (left); Dr. Harris Berman, Tufts University School of Medicine.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Dr. Mark Jacobs, Caritas Christi Health Care (left); Dr. John Fallon, Blue Cross Blue Shield Massachusetts.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

From left, James Roosevelt, Jr., Tufts Health Plan; Dr. Meredith B. Rosenthal, Harvard School of Public Health; Dr. Richard Bohmer, Harvard Business School.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

From left, Dean Paranicas, Becton, Dickinson and Company; Tom Tremble, AdvaMed; Daniel Todd, EMD Serono, Inc.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Suzanne Messere, Organogensis, Inc. (left), Emily Brower, Atrius Health/Harvard Vanguard Medical Associates.

Health Reform’s New Frontier: Balancing Cost, Value and Innovation

Dr. Wendy Everett, NEHI (left); Scott Sarazen, Ernst & Young LLP.